Pfizer acquires Bain de Soleil business from P&G; indicates plans to reposition brand.
This article was originally published in The Tan Sheet
Executive Summary
PFIZER REPOSITIONING OF BAIN DE SOLEIL WILL EMPHASIZE THERAPEUTIC BENEFITS and move away from the brand's image as a tanning product, the company said in announcing the acquisition of the suncare line from Procter & Gamble on Aug. 15. While Pfizer would not release details, the company characterized its upcoming marketing campaigns as "complex and segmented" and said they would focus on "intelligent tanning" and the brand's "therapeutic" benefits.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning